[go: up one dir, main page]

IL126159A - Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis - Google Patents

Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis

Info

Publication number
IL126159A
IL126159A IL12615997A IL12615997A IL126159A IL 126159 A IL126159 A IL 126159A IL 12615997 A IL12615997 A IL 12615997A IL 12615997 A IL12615997 A IL 12615997A IL 126159 A IL126159 A IL 126159A
Authority
IL
Israel
Prior art keywords
treating
interstitial cystitis
pharmaceutical composition
composition containing
preventing interstitial
Prior art date
Application number
IL12615997A
Other languages
English (en)
Other versions
IL126159A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL126159A0 publication Critical patent/IL126159A0/xx
Publication of IL126159A publication Critical patent/IL126159A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Threshing Machine Elements (AREA)
  • Processing Of Meat And Fish (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transplanting Machines (AREA)
  • Pistons, Piston Rings, And Cylinders (AREA)
  • Heat Treatment Of Articles (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Steroid Compounds (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL12615997A 1996-03-11 1997-03-07 Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis IL126159A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315796P 1996-03-11 1996-03-11
PCT/US1997/003410 WO1997033880A1 (en) 1996-03-11 1997-03-07 Methods of treating or preventing interstitial cystitis

Publications (2)

Publication Number Publication Date
IL126159A0 IL126159A0 (en) 1999-05-09
IL126159A true IL126159A (en) 2003-01-12

Family

ID=21758595

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12615997A IL126159A (en) 1996-03-11 1997-03-07 Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis

Country Status (23)

Country Link
EP (1) EP0888330B1 (es)
JP (1) JP2000506863A (es)
KR (1) KR19990087671A (es)
CN (1) CN1217721A (es)
AT (1) ATE239467T1 (es)
AU (1) AU730448B2 (es)
BR (1) BR9708027A (es)
CA (1) CA2250288A1 (es)
CZ (1) CZ287798A3 (es)
DE (1) DE69721747T2 (es)
DK (1) DK0888330T3 (es)
EA (1) EA001325B1 (es)
ES (1) ES2197993T3 (es)
HU (1) HUP9902884A3 (es)
IL (1) IL126159A (es)
NO (1) NO984160D0 (es)
NZ (1) NZ331811A (es)
PL (1) PL328959A1 (es)
PT (1) PT888330E (es)
RO (1) RO117296B1 (es)
UA (1) UA62926C2 (es)
WO (1) WO1997033880A1 (es)
YU (1) YU39598A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2344057C (en) 1998-09-15 2008-11-18 Eli Lilly And Company Treatment of persistent pain
WO2002078691A1 (en) * 2001-03-29 2002-10-10 Eli Lilly And Company Duloxetine for treatment of hot flashes
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
WO2007034503A2 (en) * 2005-06-20 2007-03-29 Cadila Healthcare Limited Controlled release dosage formulation of duloxetine
EP1938840A1 (en) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetine composition
EP2018860A1 (en) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetine composition
US20110008439A1 (en) * 2006-12-27 2011-01-13 Lek Pharmaceuticals D.D. Duloxetin composition
WO2009066181A2 (en) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
RU2719929C1 (ru) * 2018-12-17 2020-04-23 Юрий Анатольевич Игнашов Способ выбора лечения женщин с синдромом болезненного мочевого пузыря

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US574474A (en) * 1897-01-05 Course-indicating apparatus
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
HUP9902884A2 (en) 2000-07-28
EP0888330A4 (en) 1999-04-07
DK0888330T3 (da) 2003-09-01
AU2196297A (en) 1997-10-01
YU39598A (sh) 1999-09-27
CZ287798A3 (cs) 1999-05-12
IL126159A0 (en) 1999-05-09
NO984160L (no) 1998-09-10
DE69721747T2 (de) 2004-04-01
JP2000506863A (ja) 2000-06-06
EP0888330B1 (en) 2003-05-07
AU730448B2 (en) 2001-03-08
ATE239467T1 (de) 2003-05-15
KR19990087671A (ko) 1999-12-27
PL328959A1 (en) 1999-03-01
EP0888330A1 (en) 1999-01-07
PT888330E (pt) 2003-09-30
BR9708027A (pt) 1999-08-03
CN1217721A (zh) 1999-05-26
RO117296B1 (ro) 2002-01-30
NZ331811A (en) 2001-04-27
UA62926C2 (en) 2004-01-15
ES2197993T3 (es) 2004-01-16
HUP9902884A3 (en) 2000-12-28
DE69721747D1 (de) 2003-06-12
WO1997033880A1 (en) 1997-09-18
EA001325B1 (ru) 2001-02-26
NO984160D0 (no) 1998-09-10
EA199800816A1 (ru) 1999-02-25
CA2250288A1 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
MXPA02010322A (es) Metodos para la prevencion y tratamiento de trastornos gastrointestinales.
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
UA41355C2 (uk) Засіб для лікування нейро-сніду
IL126159A (en) Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
AU4830097A (en) Use of an extract of Cimicifuga
GR3035231T3 (en) Use of sulodexide and of medicines containing it for the treatment of diabetic nephropathy.
GR3030269T3 (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus.
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
IL120303A0 (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
PL328924A1 (en) Method of treating abuse of substances
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
AU5434899A (en) Cancer treatment
EP0182569A3 (en) Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyridoû1,2-a¨pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages
IL126157A0 (en) Method for treating excessive aggression
MD1296G2 (ro) Metoda Nicolau de tratament al lichenului plan bucal

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees